Clinical Trials Logo
  1. Home
  2. Respiratory Viral Infection
  3. NCT05620953

Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020) — SARIpreSC2  

Respiratory Viral Infection Clinical Trial

Official title:
Severe Acute Respiratory Infections Surveillance in Belgium (2011-2020, Prior to COVID-19 Pandemic)

Clinical Trial Summary

The Belgian Severe Acute Respiratory Infections network (BELSARI-net) was implemented during the influenza season 2011-2012 following the recommendations of the World Health Organization (WHO) to monitor severity of influenza viruses in hospitals. The network is composed of 6 hospitals throughout the country, two in each administrative region (Flanders, Wallonia and Brussels-Capital), and operates during the influenza epidemic period (from the last week of December or first/second week of January to the third/last week of April, depending on when influenza virus circulation is detected by the general population, based on the Influenza-like illness (ILI) network of general practitioners). Enrollment is performed for all cases matching the SARI case definition (based on WHO's case definition) and accepting to take part. A respiratory specimen is sampled systematically from each participant, and detailed clinico-epidemiological data, such as information on age, sex, symptoms and potential risk factors such as pregnancy or comorbidities (chronic respiratory diseases, asthma, chronic cardiovascular diseases, renal insufficiency, obesity, diabetes, hepatic or renal insufficiency, immunodeficiency, neuromuscular disease, pregnancy) is also collected. Participants are followed up during hospitalization for the occurrence of complications (detection of pneumonia based on chest radiography, development of acute respiratory distress syndrome (ARDS), requirement for respiratory assistance and/or for extracorporeal membrane oxygenation (ECMO), admission in intensive care unit (ICU)), or death (all-cause death). The current project includes all the samples received by the Belgian National Influenza Centre (NIC) during the influenza seasons 2011-2012 till 2019-2020.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05620953
Study type Observational
Source Sciensano
Contact
Status Completed
Phase
Start date January 20, 2012
Completion date April 2, 2020
View Details
See also
  Status Clinical Trial Phase
Terminated NCT04898023 - Zinc and Green Tea Extract for Community Respiratory Viral Infections Phase 2
Withdrawn NCT04842331 - PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT) Phase 2/Phase 3
Completed NCT02260596 - Respiratory Viral Infections in Pediatric Transplantation N/A
Not yet recruiting NCT06099873 - A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Trial of ZX-7101A Tablets to Evaluate the Efficacy and Safety in the Treatment of Uncomplicated Influenza in Adolescents Phase 3
Completed NCT04898140 - The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents
Completed NCT04611061 - Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers
Not yet recruiting NCT05618483 - Xylitol Based Nasal Spray for COVID-19 Treatment N/A
Recruiting NCT06149494 - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Phase 2
Terminated NCT04141917 - Test-and-treat for Influenza in Homeless Shelters Phase 4
Recruiting NCT06017310 - Respiferon Project
Enrolling by invitation NCT06188988 - Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
Completed NCT04141930 - Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle Phase 4
Completed NCT05846360 - The Technical and Operational Performance of the QuidelOrtho Savanna RVP4 Analyzer
Completed NCT04532411 - COVID-19 Testing Sample Acquisition Throughput and Efficiency
Active, not recruiting NCT04258059 - Wells and Enteric Disease Transmission Trial (WET - Trial) N/A
Active, not recruiting NCT04482673 - Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection Phase 4
Not yet recruiting NCT05946538 - Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics N/A
Recruiting NCT05092607 - Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19 N/A
Recruiting NCT05913700 - Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Recruiting NCT04826991 - Wells and Enteric Disease Transmission N/A